Keiichiro Mori

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 352 publications

Diet and risk of bladder cancer: a systematic review of epidemiological evidence.

Diet and risk of bladder cancer: a systematic review of epidemiological evidence.

Journal: BJU international

Published: August 24, 2026

Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.

Subsequent systemic therapy initiation after first-line discontinuation in metastatic renal cell carcinoma: insights from a Japanese real-world cohort.

Journal: ESMO real world data and digital oncology

Published: July 13, 2026

Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.

Timing-dependent skin toxicity phenotypes during enfortumab vedotin plus pembrolizumab therapy for advanced urothelial carcinoma.

Journal: International journal of clinical oncology

Published: June 04, 2026

First-Line Systemic Treatments of Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-Analysis.

First-Line Systemic Treatments of Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-Analysis.

Journal: The Journal of urology

Published: May 22, 2026

Prognostic significance of non-muscle-invasive late recurrence after intravesical bacillus Calmette-Guérin therapy in bladder cancer: a multicenter, retrospective real-world study (the Japan Urological Oncology Group).

Prognostic significance of non-muscle-invasive late recurrence after intravesical bacillus Calmette-Guérin therapy in bladder cancer: a multicenter, retrospective real-world study (the Japan Urological Oncology Group).

Journal: Japanese journal of clinical oncology

Published: May 15, 2026

Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

Perioperative and survival outcomes of synchronous vs. metachronous upper tract urothelial carcinoma among bladder cancer patients treated with radical cystectomy and nephroureterectomy: Results from an International Multicenter Collaborative Study-On behalf of the Young Academic Urology (YAU) Urothelial Working Group.

Journal: Urologic oncology

Published: April 20, 2026

Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401.

Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401.

Journal: Cancers

Published: April 13, 2026

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Nephroureterectomy for upper tract urothelial carcinoma recurrence in bladder cancer patients treated with radical cystectomy: a multicentric propensity score matched analysis on predictors, practice patterns and survival outcomes.

Journal: World journal of urology

Published: April 12, 2026

Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study.

Differential impact of host-related factors on survival outcomes between IO+IO and IO+TKI in metastatic renal cell carcinoma: a multicenter retrospective study.

Journal: International journal of clinical oncology

Published: April 11, 2026

Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma.

Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma.

Journal: Anticancer research

Published: April 02, 2026

Efficacy and safety of first-line immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients on hemodialysis.

Efficacy and safety of first-line immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients on hemodialysis.

Journal: Urologic oncology

Published: April 02, 2026

Correction: Hounsfield unit to serum pentosidine ratio predicts screw loosening after lumbar interbody fusion.

Correction: Hounsfield unit to serum pentosidine ratio predicts screw loosening after lumbar interbody fusion.

Journal: BMC musculoskeletal disorders

Published: March 25, 2026

Showing 1-12 of 352

Last Updated: 09/26/2026